Remicade (infliximab) - J&J
Taltz (ixekizumab) - Eli Lilly
Bimzelx (bimekizumab-bkzx) - UCB
Ebglyss (lebrikizumab-lbkz) - Eli Lilly
Cimzia (certolizumab pegol) - Astellas, UCB
Rituxan (rituximab) - Roche
Tremfya (guselkumab) - J&J
Xolair (omalizumab) - Roche, Novartis
Ilumya (tildrakizumab-asmn) - Sun Pharma, Almirall
Cosentyx (secukinumab) - Novartis
Adbry (tralokinumab-ldrm) - LEO Pharma, AstraZeneca
Skyrizi (risankizumab-rzaa) - AbbVie, Boehringer Ingelheim
Siliq (brodalumab) - Bausch Health
Dupixent (dupilumab) - Sanofi, Regeneron
https://s3.eu-central-1.amazonaws.com/m-anage.com.storage.eadv/abstracts_symposium_2026/61795.pdf
 
Maksym Breslavets 1; Chelsea Butler2
 
May 13, 2026
 
Prev Next